JoinFridays vs Maximus: Price, drugs and flexibility compared
Comparing JoinFridays vs Maximus quickly: JoinFridays emphasizes a lower entry price and flexible cancel-anytime terms, while Maximus offers a simple flat semaglutide plan filled through trusted U.S. pharmacies. Early verdict: choose JoinFridays for the lowest starting price and access to compounded tirzepatide; choose Maximus for a steady low flat rate and domestic pharmacy fulfillment.
See JoinFridays starting at $117/month
Direct comparison overview: JoinFridays vs Maximus
This comparison focuses on five clear differences supported by source facts: starting price and pricing structure, medication options, membership and cancellation terms, telemedicine and pharmacy sourcing, and available outcome or platform evidence. All claims below reflect the supplied provider statements and qualifiers.
1. Starting price and pricing structure
JoinFridays: Starting at $117/month. The platform lists a standalone month at $249 and multi-month plans that lower effective monthly cost, with a twelve month plan averaging $150/month. Promo codes and multi-month commitments can change the effective price. JoinFridays advertises active promo codes and describes multi-month pricing examples such as a three-month plan at $596 and six months at $1,050.
View JoinFridays pricing and promos
Maximus: Priced at $132.99/month as a low flat rate for compounded semaglutide. The provider positions this as a straightforward direct-pay model with transparent monthly pricing. Maximus highlights free expedited shipping in captured landing content and states the monthly rate is what you pay without insurance billing.
2. Medication options and availability
JoinFridays: Offers both compounded tirzepatide and compounded semaglutide on one platform and also lists name-brand options separately. The source explicitly states tirzepatide is available as compounded medication and that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. JoinFridays frames tirzepatide as “Most Effective” and semaglutide as “Most Affordable.”
Maximus: Focuses on compounded semaglutide for weight loss at $132.99/month. The source provides detailed semaglutide messaging and limited public detail on tirzepatide availability, noting that tirzepatide program detail is not published in the supplied evidence.
3. Membership, cancellation and care model
JoinFridays: Emphasizes no long-term contracts, no membership fees beyond treatment cost, and the ability to cancel anytime. The platform pairs medication with clinician-guided care and personalized dosing guidance rather than a templated protocol according to the supplied description.
Maximus: Operates as a direct-pay telemedicine model with no membership fees and prescriptions approved by licensed doctors. The evidence highlights convenient telemedicine access with no clinic visits required and a straightforward monthly fee, but does not describe a cancel-anytime membership model in detail beyond transparent pricing.
4. Telemedicine, pharmacy sourcing and clinician review
JoinFridays: Prescribes through licensed clinicians with personalized guidance; the source states treatment is available only when a licensed clinician determines it is medically appropriate. It notes compounded medications, when offered, are not FDA-approved.
Maximus: Prescriptions are approved by licensed doctors and filled through trusted U.S. pharmacies, with telemedicine access and no in-person clinic visits required. Maximus highlights domestic pharmacy fulfillment and free expedited shipping in the captured content.
5. Track record, outcomes and platform evidence
JoinFridays: Marketed as competing on flexible terms, competitive pricing, and personalized clinician-guided care. The source claims aggressive promo codes and positions JoinFridays as a serious alternative for patients seeking a full-service GLP-1 experience without long-term commitment.
Maximus: Described as a smaller, newer platform with fewer public reviews and a thinner public track record; its strength is a low flat rate and domestic pharmacy sourcing. The supplied evidence includes semaglutide outcome statistics cited from studies but does not provide platform-specific guarantees.
| Criteria | JoinFridays | Maximus |
|---|---|---|
| Starting price | Starting at $117/month | $132.99/month |
| Medications offered | Compounded tirzepatide and semaglutide; name-brand listed separately | Compounded semaglutide; limited tirzepatide detail |
| Membership and cancellation | No long-term contracts; cancel anytime; no membership fees | No membership fees; direct-pay monthly model |
| Clinician and pharmacy | Clinician-guided care; treatment subject to clinician review; compounded meds not FDA-approved | Prescriptions approved by licensed doctors; filled through trusted U.S. pharmacies |
| Promos and pricing nuance | Active promo codes and multi-month pricing examples | Flat low monthly rate; free expedited shipping mentioned |
| Track record | Positioned as full-service telehealth alternative with aggressive promo codes | Smaller, newer platform with fewer public reviews |
How to pick between JoinFridays vs Maximus
Both providers use compounded medications, and both note that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. If the supplied evidence does not state a detail you need, that information was not supplied and should be confirmed with the provider.
See Maximus semaglutide plan at $132.99/month
Compare JoinFridays programs and clinician care
Conclusion and quick recommendation
JoinFridays vs Maximus boils down to price and medication breadth vs a simple flat semaglutide plan with U.S. pharmacy fulfillment. Choose JoinFridays if you prioritize the lowest starting price, access to both compounded tirzepatide and semaglutide on one platform, and cancel-anytime terms. Choose Maximus if you prefer a steady low flat semaglutide monthly rate with prescriptions filled through trusted U.S. pharmacies and licensed doctor approval.